Migliaccio-Walle K

References (3)

Title : NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? - Getsios_2007_Pharmacoeconomics_25_997
Author(s) : Getsios D , Migliaccio-Walle K , Caro JJ
Ref : Pharmacoeconomics , 25 :997 , 2007
Abstract : Getsios_2007_Pharmacoeconomics_25_997
ESTHER : Getsios_2007_Pharmacoeconomics_25_997
PubMedSearch : Getsios_2007_Pharmacoeconomics_25_997
PubMedID: 18047386

Title : Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries - Caro_2004_Drugs.Aging_21_677
Author(s) : Caro J , Salas M , Ward A , Getsios D , Migliaccio-Walle K , Garfield F
Ref : Drugs & Aging , 21 :677 , 2004
Abstract : Caro_2004_Drugs.Aging_21_677
ESTHER : Caro_2004_Drugs.Aging_21_677
PubMedSearch : Caro_2004_Drugs.Aging_21_677
PubMedID: 15287825

Title : Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis - Caro_2003_BMC.Geriatr_3_6
Author(s) : Caro J , Getsios D , Migliaccio-Walle K , Ishak J , El-Hadi W
Ref : BMC Geriatr , 3 :6 , 2003
Abstract : Caro_2003_BMC.Geriatr_3_6
ESTHER : Caro_2003_BMC.Geriatr_3_6
PubMedSearch : Caro_2003_BMC.Geriatr_3_6
PubMedID: 14675494